NCH Capital
NCH Capital is a venture capital firm based in New York, United States. This profile covers what we know about NCH Capital and how founders can get in front of it in 2026.
NCH Capital is an investment management company specializing in investment, management, and technical services.
- Location
- New York, United States
- Founded
- 1993
- Team size
- 101-250
How to pitch NCH Capital
The founders who hear back from NCH Capital lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with NCH Capital
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "NCH Capital." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/nch-capital
Frequently Asked Questions
What is NCH Capital?
NCH Capital is a venture capital firm based in New York, United States. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is NCH Capital based?
NCH Capital is based in New York, United States. You can reach out from anywhere with a pitch that matches its focus.
How do I contact NCH Capital?
Unlock a verified email for NCH Capital and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.